Advisory Committee on Breast Cancer in Young Women (ACBCYW), 18601 [2013-06946]

Download as PDF 18601 Federal Register / Vol. 78, No. 59 / Wednesday, March 27, 2013 / Notices For Form 2: Antimicrobial Susceptibility Testing, the annual frequency of responses per respondent is 1,452 (121 isolates × 12 months). Based on previous laboratory experience, the estimated burden of completing Form 2 for each participating laboratory is 1 hour per response, which includes the time required for laboratory processing of the patient’s isolate, gathering and maintaining the data needed, and completing and reviewing the collection of information. For Form 3: Control Strain Susceptibility Testing, a ‘‘response’’ is defined as the processing and recording of Regional laboratory data for a set of seven control strains. It takes approximately 12 minutes to process and record the Regional laboratory data on Form 3 for one set of seven control strains, of which there are 4 sets. The number of responses per respondent is 48 (4 sets × 12 months). There are no additional costs to respondents. ESTIMATE OF ANNUALIZED BURDEN HOURS Number of responses per respondent Number of respondents Avg. burden per response (in hours) Total annual burden (in hours) Type of respondent Form name Clinic .............................. Laboratory ...................... Demographic Clinical Data Form 1 ..................... Antimicrobial Susceptibility Testing Form 2 ........ Control Strain Susceptibility Testing Form 3 ....... 30 5 5 240 1,452 48 11/60 1 12/60 1,320 7,260 48 Total ........................ .............................................................................. 40 ........................ ........................ 8,628 Dated: March 21, 2013. Ron A. Otten, Director, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2013–07059 Filed 3–26–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention mstockstill on DSK4VPTVN1PROD with NOTICES Advisory Committee on Breast Cancer in Young Women (ACBCYW) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 9:00 a.m.–11:00 a.m. EDT, April 16, 2013. Place: The meeting will be held via teleconference. Teleconference login information is as follows: For Public: TOLL–FREE PHONE #: 800–857–4875 Participant passcode: 9377 Net Conference URL: https:// www.mymeetings.com/nc/join/ Conference number: PW8921926 Audience passcode: 9377 or Public can join the event directly: https:// www.mymeetings.com/nc/ join.php?i=PW8921926&p=9377&t=c There is also a toll number for anyone outside of the USA: TOLL #: 1–212–287–1661 Participant passcode: 9377 Please go to the ACBCYW meeting Web page to register for this meeting: http://www.cdc.gov/cancer/breast/ what_cdc_is_doing/conference.htm. VerDate Mar<15>2010 18:10 Mar 26, 2013 Jkt 229001 Status: Open to the public, limited only by the number of phone lines available. Purpose: The committee provides advice and guidance to the Secretary, HHS; the Assistant Secretary for Health; and the Director, CDC, regarding the formative research, development, implementation and evaluation of evidence-based activities designed to prevent breast cancer (particularly among those at heightened risk) and promote the early detection and support of young women who develop the disease. The advice provided by the Committee will assist in ensuring scientific quality, timeliness, utility, and dissemination of credible appropriate messages and resource materials. Matters To Be Discussed: The agenda will include discussions on approaches to increase awareness of clinicians/ practitioners regarding topics such as breast health, symptoms, diagnosis, and treatment of breast cancer in young women; and information needs and delivery mechanisms for women at higher risks for developing breast cancer. These discussions will be directed toward the final review and approval of formal recommendations on these topics. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Temeika L. Fairley, Ph.D., Designated Federal Officer, National Center for Chronic Disease Prevention and Health Promotion, CDC, 4770 Buford Highway NE., Mailstop K52, Atlanta, Georgia, 30341, Telephone (770) 488–4518, Fax (770) 488–4760, Email: acbcyw@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and Agency for Toxic Substances and Disease Registry. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–06946 Filed 3–26–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Respirator Certification Fees; Public Meeting The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of public meeting. AGENCY: SUMMARY: The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) announces a public meeting. The purpose of this meeting is to allow stakeholders to present information the impact of an increase on respirator fees on individual respirator manufacturers, the respirator market, or on those industries that rely on NIOSH approved respiratory equipment. DATES: April 30, 2013, 10 a.m. to 4 p.m. EDT, or after the last public commenter has spoken, whichever occurs first. ADDRESSES: U.S. Office of Surface Mining, Three Parkway Center E:\FR\FM\27MRN1.SGM 27MRN1

Agencies

[Federal Register Volume 78, Number 59 (Wednesday, March 27, 2013)]
[Notices]
[Page 18601]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06946]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Breast Cancer in Young Women (ACBCYW)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:
    Time and Date: 9:00 a.m.-11:00 a.m. EDT, April 16, 2013.
    Place: The meeting will be held via teleconference.
    Teleconference login information is as follows: For Public:
    TOLL-FREE PHONE #: 800-857-4875
    Participant passcode: 9377
    Net Conference URL: https://www.mymeetings.com/nc/join/
    Conference number: PW8921926
    Audience passcode: 9377 or Public can join the event directly: 
https://www.mymeetings.com/nc/join.php?i=PW8921926&p=9377&t=c
    There is also a toll number for anyone outside of the USA:
    TOLL #: 1-212-287-1661
    Participant passcode: 9377
    Please go to the ACBCYW meeting Web page to register for this 
meeting: http://www.cdc.gov/cancer/breast/what_cdc_is_doing/conference.htm.
    Status: Open to the public, limited only by the number of phone 
lines available.
    Purpose: The committee provides advice and guidance to the 
Secretary, HHS; the Assistant Secretary for Health; and the Director, 
CDC, regarding the formative research, development, implementation and 
evaluation of evidence-based activities designed to prevent breast 
cancer (particularly among those at heightened risk) and promote the 
early detection and support of young women who develop the disease. The 
advice provided by the Committee will assist in ensuring scientific 
quality, timeliness, utility, and dissemination of credible appropriate 
messages and resource materials.
    Matters To Be Discussed: The agenda will include discussions on 
approaches to increase awareness of clinicians/practitioners regarding 
topics such as breast health, symptoms, diagnosis, and treatment of 
breast cancer in young women; and information needs and delivery 
mechanisms for women at higher risks for developing breast cancer. 
These discussions will be directed toward the final review and approval 
of formal recommendations on these topics.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Temeika L. Fairley, Ph.D., 
Designated Federal Officer, National Center for Chronic Disease 
Prevention and Health Promotion, CDC, 4770 Buford Highway NE., Mailstop 
K52, Atlanta, Georgia, 30341, Telephone (770) 488-4518, Fax (770) 488-
4760, Email: acbcyw@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and Agency for 
Toxic Substances and Disease Registry.

Dana Redford,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2013-06946 Filed 3-26-13; 8:45 am]
BILLING CODE 4163-18-P